Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Biology » Proteins » Serpins and Protein Kinase Inhibitors: Novel Functions, Structural Features and Molecular Mechanisms Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Central Asia: Perspectives and Present Challenges
$144.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Targeting the Epidermal Growth Factor Receptor Pathway in Glioblastoma Multiforme and Other Intracranial Malignancies pp.89-106
Tell A Friend
 
Tell someone you know about this product.
Targeting the Epidermal Growth Factor Receptor Pathway in Glioblastoma Multiforme and Other Intracranial Malignancies pp.89-106 $100.00
Authors:  (Marc-Eric Halatsch, Georg Karpel-Massler - Dept of Neurosurgery, Univ. of Heidelberg, Heidelberg, Germany)
Abstract:
Limited therapeutic options exist for glioblastoma multiforme (GBM), the most common primary central nervous system tumor, and recurrence is common. Standard therapy is surgical resection, where possible, and radiotherapy. Adjuvant chemotherapy provides only a modest survival benefit, and new therapies are urgently needed. Dysregulated epidermal growth factor receptor (HER1/EGFR) is found in 40-50% of GBM. As the intracellular tyrosine kinase (TK) of the HER1/EGFR activates signalling cascades leading to cell proliferation, angiogenesis and inhibition of apoptosis, HER1/EGFR represents an attractive therapeutic target. HER1/EGFR TK inhibitors are in advanced clinical development for glioma, and a number of trials are in progress, or have recently been completed. Although data from experimental studies seem promising, proof of a significant clinical benefit is lacking. A problem that has to be further addressed is the prediction of the individual tumor response to HER1/EGFR TK inhibitors based on molecular determinants. This chapter reviews the role of HER1/EGFR TK inhibitors in the treatment of GBM and other intracranial malignancies. 


Available Options:
Version:
This Item Is Currently Unavailable.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Targeting the Epidermal Growth Factor Receptor Pathway in Glioblastoma Multiforme and Other Intracranial Malignancies pp.89-106